Order and disorder in the physiological membrane binding of α-synuclein
- PMID: 29100107
- DOI: 10.1016/j.sbi.2017.09.004
Order and disorder in the physiological membrane binding of α-synuclein
Abstract
α-Synuclein (αS) is a neuronal protein that localises predominantly at the presynaptic terminals, and whose fibrillar aggregates are the major constituents of Lewy bodies in Parkinson's disease. In vivo αS is partitioned between water-soluble and membrane-bound states, and this highly regulated equilibrium influences its biological behaviour under both physiological and pathological conditions. Here we discuss the sequence and structural determinants underlying the transition between the unstructured cytosolic and partially structured membrane-bound states of αS. The balance between order and disorder in this protein system is crucial for the overall regulation of the membrane affinity, the ability to induce the clustering of synaptic vesicles, and the tendency to self assemble into amyloid fibrils at the surface of biological membranes.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
The N-terminal Acetylation of α-Synuclein Changes the Affinity for Lipid Membranes but not the Structural Properties of the Bound State.Sci Rep. 2020 Jan 14;10(1):204. doi: 10.1038/s41598-019-57023-4. Sci Rep. 2020. PMID: 31937832 Free PMC article.
-
Structural basis of synaptic vesicle assembly promoted by α-synuclein.Nat Commun. 2016 Sep 19;7:12563. doi: 10.1038/ncomms12563. Nat Commun. 2016. PMID: 27640673 Free PMC article.
-
Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.Biochemistry. 2000 Mar 14;39(10):2552-63. doi: 10.1021/bi991447r. Biochemistry. 2000. PMID: 10704204
-
Mechanistic aspects of Parkinson's disease: alpha-synuclein and the biomembrane.Cell Biochem Biophys. 2007;47(2):285-99. doi: 10.1007/s12013-007-0014-9. Cell Biochem Biophys. 2007. PMID: 17652776 Review.
-
α-Synuclein and biological membranes: the danger of loving too much.Chem Commun (Camb). 2023 Jul 13;59(57):8769-8778. doi: 10.1039/d3cc01682j. Chem Commun (Camb). 2023. PMID: 37345454 Free PMC article. Review.
Cited by
-
The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability.Cell. 2022 Jun 9;185(12):2035-2056.e33. doi: 10.1016/j.cell.2022.05.008. Cell. 2022. PMID: 35688132 Free PMC article.
-
Alpha-Synuclein Aggregation in Parkinson's Disease.Front Med (Lausanne). 2021 Oct 18;8:736978. doi: 10.3389/fmed.2021.736978. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34733860 Free PMC article. Review.
-
α-Synuclein in traumatic and vascular diseases of the central nervous system.Aging (Albany NY). 2020 Nov 7;12(21):22313-22334. doi: 10.18632/aging.103675. Epub 2020 Nov 7. Aging (Albany NY). 2020. PMID: 33188159 Free PMC article. Review.
-
Hypoxia Pathways in Parkinson's Disease: From Pathogenesis to Therapeutic Targets.Int J Mol Sci. 2024 Sep 29;25(19):10484. doi: 10.3390/ijms251910484. Int J Mol Sci. 2024. PMID: 39408813 Free PMC article. Review.
-
Impaired dopamine metabolism in Parkinson's disease pathogenesis.Mol Neurodegener. 2019 Aug 20;14(1):35. doi: 10.1186/s13024-019-0332-6. Mol Neurodegener. 2019. PMID: 31488222 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- G-1508/PUK_/Parkinson's UK/United Kingdom
- 1656811/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- MR/N000676/1/MRC_/Medical Research Council/United Kingdom
- BB/M023923/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- 104933/Z/14/Z/WT_/Wellcome Trust/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources